New pill tested for aggressive breast cancer
Disease control
Completed
This early-stage trial tested a daily pill called leflunomide in women with metastatic triple negative breast cancer (TNBC), a hard-to-treat form of the disease. The study first aimed to find a safe dose and then to see if the drug could help control the cancer. It involved 17 wo…
Phase: PHASE1, PHASE2 • Sponsor: Joseph Sparano • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC